A Comprehensive Review of Dilated Cardiomyopathy in Pre-clinical Animal Models in Addition to Herbal Treatment Options and Multi-modality Imaging Strategies.
Navneet KaurRahul Kumar SharmaAjay Singh KushwahaNisha SinghShilpa ThakurPublished in: Cardiovascular & hematological disorders drug targets (2023)
Dilated cardiomyopathy (DCM) is distinguished by ventricular chamber expansion, systolic dysfunction, and normal left ventricular (LV) wall thickness, and is mainly caused due to genetic or environmental factors; however, its aetiology is undetermined in the majority of patients. The focus of this work is on pathogenesis, small animal models, as well as the herbal medicinal approach, and the most recent advances in imaging modalities for patients with dilated cardiomyopathy. Several small animal models have been proposed over the last few years to mimic various pathomechanisms that contribute to dilated cardiomyopathy. Surgical procedures, gene mutations, and drug therapies are all characteristic features of these models. The pros and cons, including heart failure stimulation of extensively established small animal models for dilated cardiomyopathy, are illustrated, as these models tend to procure key insights and contribute to the development of innovative treatment techniques for patients. Traditional medicinal plants used as treatment in these models are also discussed, along with contemporary developments in herbal therapies. In the last few decades, accurate diagnosis, proper recognition of the underlying disease, specific risk stratification, and forecasting of clinical outcome, have indeed improved the health of DCM patients. Cardiac magnetic resonance (CMR) is the bullion criterion for assessing ventricular volume and ejection fraction in a reliable and consistent direction. Other technologies, like strain analysis and 3D echocardiography, have enhanced this technique's predictive and therapeutic potential. Nuclear imaging potentially helps doctors pinpoint the causative factors of left ventricular dysfunction, as with cardiac sarcoidosis and amyloidosis.
Keyphrases
- left ventricular
- ejection fraction
- heart failure
- end stage renal disease
- aortic stenosis
- magnetic resonance
- newly diagnosed
- chronic kidney disease
- high resolution
- peritoneal dialysis
- healthcare
- acute myocardial infarction
- computed tomography
- blood pressure
- mitral valve
- oxidative stress
- patient reported outcomes
- magnetic resonance imaging
- hypertrophic cardiomyopathy
- cardiac resynchronization therapy
- genome wide
- social media
- smoking cessation
- atrial fibrillation
- transcatheter aortic valve replacement
- medical students
- fluorescence imaging